SUSS MicroTec Concludes Contract Negotiations to Acquire HamaTech

SUSS MicroTec AG, which is listed in the Prime Standard of Deutsche Börse AG, today announced the conclusion of contract negotiations to acquire HamaTech APE GmbH & Co. KG, a wholly owned subsidiary of Singulus Technologies AG.

Frank Averdung, CEO SUSS MicroTec AG, and Roland Lacher, CEO Singulus AG, Signing the HamaTech Purchase Agreement, 12 January 2010 (Photo: Business Wire

Yesterday night, both parties signed a corresponding purchase agreement, subject to the negotiated closing conditions. The agreement stipulates a purchase price of EUR 4.5 million plus a further EUR 4.5 million for the acquisition of the land and company building at the Sternenfels site. The closing date of the transaction is set for January 2010.

Both contractual parties (buyer and seller) had already signed a comprehensive term sheet for the acquisition of HamaTech APE on December 6, 2009.

The purchase price of EUR 4.5 million is comprised of a fixed and variable portion. The fixed component amounts to EUR 3.5 million and will be paid in cash. The variable earn-out component amounts to EUR 1.0 million and is linked to the future sales performance of HamaTech APE in the year, 2010.

HamaTech APE has established itself in the semiconductor industry as a leading global supplier of equipment for cleaning photo masks. It employs approximately 80 staff at its Sternenfels site and its international subsidiaries. In the 2009 fiscal year, the Company is expected to generate sales of EUR 11 million.

With the acquisition, the SUSS MicroTec Group is expanding its existing Coater/Developer product portfolio. "HamaTech APE's 20 years of experience in developing processes and equipment along with its highly innovative cleaning technology ideally complement SUSS MicroTec's core competency of critical wet processing in semiconductor production," Frank Averdung, Chief Executive Officer of SUSS MicroTec AG, commented at the contract signing ceremony. "The modern production site at Sternenfels is ideally suited for expansion into a group-wide competence center for “wet processing”. We therefore intend to relocate the Coater and Developer production set up in neighboring Vaihingen to the Sternenfels plant," Frank Averdung continued.

"The high performance and efficiency of our systems have turned us into the globally recognized market leader in our sector. We address the most demanding requirements of 193i conventional lithography and, in addition, we are today the only supplier of solutions for cleaning masks for EUV (extreme ultraviolet) lithography," Wilma Koolen-Hermkens, Managing Director of HamaTech APE, remarked. "We look forward to being able to offer our extensive expertise to our customers as part of the SUSS MicroTec Group in the future."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    SUSS MicroTec AG. (2019, February 14). SUSS MicroTec Concludes Contract Negotiations to Acquire HamaTech. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=15430.

  • MLA

    SUSS MicroTec AG. "SUSS MicroTec Concludes Contract Negotiations to Acquire HamaTech". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=15430>.

  • Chicago

    SUSS MicroTec AG. "SUSS MicroTec Concludes Contract Negotiations to Acquire HamaTech". AZoNano. https://www.azonano.com/news.aspx?newsID=15430. (accessed November 21, 2024).

  • Harvard

    SUSS MicroTec AG. 2019. SUSS MicroTec Concludes Contract Negotiations to Acquire HamaTech. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=15430.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.